Greater increase in urinary hepcidin predicts protection from acute kidney injury after cardiopulmonary bypass

Nephrology Dialysis Transplantation

Volumn 27, Issue 2, 2012, Pages 595-602

  Prowle, John R ^a   Ostland, Vaughn ^b   Calzavacca, Paolo ^a   Licari, Elisa ^a   Ligabo, E Valentina ^a   Echeverri, Jorge E ^a   Bagshaw, Sean M ^c   Haase Fielitz, Anja ^d   Haase, Michael ^d   Westerman, Mark ^b   Bellomo, Rinaldo ^a  

^a AUSTIN HOSPITAL   (Australia)

^b Intrinsic LifeSciences LLC   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

acute kidney injury; biomarkers; cardiopulmonary bypass; critical illness; hepcidin

Indexed keywords

ATORVASTATIN; HEPCIDIN; PLACEBO;

ACUTE KIDNEY FAILURE; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RENAL PROTECTION; SENSITIVITY AND SPECIFICITY;

ACUTE KIDNEY INJURY; AGED; ANTIMICROBIAL CATIONIC PEPTIDES; AREA UNDER CURVE; BIOLOGICAL MARKERS; COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY STENOSIS; CREATININE; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SURGICAL PROCEDURES, ELECTIVE; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; VICTORIA;

EID: 84856884859     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr387     Document Type: Article

References (48)

1. Chertow GM, Burdick E, Honour M et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16: 3365-3370
2. Uchino S. Creatinine. Curr Opin Crit Care 2010; 16: 562-567
3. Bellomo R, Ronco C, Kellum JA et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212
4. Doi K, Yuen PST, Eisner C et al. Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J Am Soc Nephrol 2009; 20: 1217-1221
5. Mishra J, Ma Q, Prada A et al. Identification of neutrophil gelatinaseassociated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003; 14: 2534-2543
6. Ichimura T, Bonventre JV, Bailly V et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 1998; 273: 4135-4142
7. Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294: 813-818
8. Haase M, Bellomo R, Haase-Fielitz A. Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypassassociated acute kidney injury. J Am Coll Cardiol 2010; 55: 2024-2033
9. Ho J, Lucy M, Krokhin O et al. Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study. AmJ Kidney Dis 2009; 53: 584-595
10. Prowle JR, Westerman M, Bellomo R. Urinary hepcidin: an inverse biomarker of acute kidney injury after cardiopulmonary bypass? Curr Opin Crit Care 2010; 16: 540-544
11. Prowle JR, Licari E, Calzavacca P et al. Peri-operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the Cardiopulmonary bypass, Renal injury & Atorvastatin Trial. ClinicalTrials.gov NCT00910221. Intensive Care Med 2010; 36 (Suppl 2): S88
12. Herget-Rosenthal S, Marggraf G, Husing J et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004; 66: 1115-1122
13. Koyner JL, Vaidya VS, Bennett MR et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 2010; 5: 2154-2165
14. Haase M, Bellomo R, Devarajan P et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 54: 1012-1024
15. Haase M, Bellomo R, Devarajan P et al. Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults. Ann Thorac Surg 2009; 88: 124-130
16. Ganz T, Olbina G, Girelli D et al. Immunoassay for human serum hepcidin. Blood 2008; 112: 4292-4297
17. Swinkels DW, Girelli D, Laarakkers C et al. Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS One 2008; 3: e2706
18. Hanley JA,McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36
19. Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3: 32-35
20. Haase M, Haase-Fielitz A, Bellomo R et al. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med 2009; 37: 39-47
21. Hoppe M, Lönnerdal B, Hossain B et al. Hepcidin, interleukin-6 and hematological iron markers in males before and after heart surgery. J Nutr Biochem 2009; 20: 11-16
22. Laarakkers CMM, Wetzels JFM, Swinkels DW. Hepcidin levels in acute kidney injury following cardiopulmonary bypass grafting. Am J Kidney Dis 2009; 54: 979, author reply 980
23. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003; 102: 783-788
24. Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Acta Haematol 2009; 122: 78-86
25. Nemeth E, Tuttle MS, Powelson J et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306: 2090-2093
26. Nemeth E, Valore EV, Territo M et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003; 101: 2461-2463
27. Gueret G, Lion F, Guriec N et al. Acute renal dysfunction after cardiac surgery with cardiopulmonary bypass is associated with plasmatic IL6 increase. Cytokine 2009; 45: 92-98
28. Vermeulen Windsant IC, Snoeijs MG, Hanssen SJ et al. Hemolysis is associated with acute kidney injury during major aortic surgery. Kidney Int 2010; 77: 913-920
29. Ostermann M, Chang RW. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 2007; 35: 1837-1843, quiz 1852
30. Uchino S, Bellomo R, Goldsmith D et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006; 34: 1913-1917
31. Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 2008; 73: 538-546
32. Hoste EA, Kellum JA. Acute kidney injury: epidemiology and diagnostic criteria. Curr Opin Crit Care 2006; 12: 531-537
33. Liangos O, Tighiouart H, Perianayagam MC et al. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers 2009; 14: 423-431
34. McIlroy DR, Wagener G, Lee HT. Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol 2010; 5: 211-219
35. Ramesh G, Krawczeski CD, Woo JG et al. Urinary netrin-1 is an early predictive biomarker of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 2010; 5: 395-401
36. Englberger L, Suri RM, Li Z et al. Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit Care 2011; 15: R16
37. Dasta JF, Kane-Gill SL, Durtschi AJ et al. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant 2008; 23: 1970-1974
38. Dennen P, Altmann C, Kaufman J et al. Urine interleukin-6 is an early biomarker of acute kidney injury in children undergoing cardiac surgery. Crit Care 2010; 14: R181
39. Koyner JL, Bennett MR, Worcester EM et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int 2008; 74: 1059-1069
40. Nejat M, Pickering JW, Walker RJ et al. Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Crit Care 2010; 14: R85
41. Mori K, Lee HT, Rapoport D et al. Endocytic delivery of lipocalinsiderophore-iron complex rescues the kidney fromischemia-reperfusion injury. J Clin Invest 2005; 115: 610-621
42. Malyszko J, Tesar V, Macdougall IC. Neutrophil gelatinaseassociated lipocalin and hepcidin: what do they have in common and is there a potential interaction? Kidney Blood Press Res 2010; 33: 157-165
43. Détivaud L, Nemeth E, Boudjema K et al. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood 2005; 106: 746-748
44. Peters HP, Laarakkers CM, Swinkels DW et al. Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate. Nephrol Dial Transplant 2010; 25: 848-853
45. Metzger J, Kirsch T, Schiffer E et al. Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury. Kidney Int 2010; 78: 1252-1262
46. Baliga R, Zhang Z, Baliga M et al. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 1998; 53: 394-401
47. Paller MS, Hedlund BE. Role of iron in postischemic renal injury in the rat. Kidney Int 1988; 34: 474-480
48. Walker PD, Shah SV. Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats. J Clin Invest 1988; 81: 334-341